Sara Nik

Sara Nik, PhD, is a seasoned professional in the biotech sector, currently serving as a Senior Associate in Equity Research at H.C. Wainwright & Co., LLC since March 2021. Prior experience includes roles as a Junior Scientist at Cellectis, a Project Leader at The Solution Lab, Inc., and a PhD Candidate at Albert Einstein College of Medicine, where research focused on the impact of disease-associated mutations in RNA splicing factors on DNA damage responses. Additionally, Sara Nik worked as a Research Assistant in the Department of Pathology & Cell Biology at Columbia University Irving Medical Center. Sara Nik holds a Ph.D. in Biomedical Sciences with a focus on Developmental and Molecular Biology from Albert Einstein College of Medicine, a Master's degree in Biotechnology from Columbia University, and a Bachelor's degree in Pharmacology from Stony Brook University.